BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 22768988)

  • 1. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.
    Huguet F; Goodman KA; Azria D; Racadot S; Abrams RA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1355-64. PubMed ID: 22768988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison of doses to organs at risk using 3-D conformal radiotherapy versus intensity modulated radiotherapy in postoperative radiotherapy of periampullary cancers: implications for radiation dose escalation.
    Bahl A; Kapoor R; Tomar P; Singh OA; Gupta R; Sharma SC
    JOP; 2013 Jan; 14(1):39-43. PubMed ID: 23306333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma.
    Brown MW; Ning H; Arora B; Albert PS; Poggi M; Camphausen K; Citrin D
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):274-83. PubMed ID: 16618582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy.
    Nakamura A; Shibuya K; Matsuo Y; Nakamura M; Shiinoki T; Mizowaki T; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):369-75. PubMed ID: 22381898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
    Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.
    Thompson RF; Mayekar SU; Zhai H; Both S; Apisarnthanarax S; Metz JM; Plastaras JP; Ben-Josef E
    Med Phys; 2014 Aug; 41(8):081711. PubMed ID: 25086521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
    Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
    Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric modulated arc therapy for advanced pancreatic cancer.
    Eppinga W; Lagerwaard F; Verbakel W; Slotman B; Senan S
    Strahlenther Onkol; 2010 Jul; 186(7):382-7. PubMed ID: 20582394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
    Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer.
    Nakamura M; Shibuya K; Nakamura A; Shiinoki T; Matsuo Y; Nakata M; Sawada A; Mizowaki T; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1619-26. PubMed ID: 21477941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosimetric impact of breath-hold in the treatment of hepatocellular carcinoma by conformal radiation therapy].
    Kubas A; Chapet O; Merle P; Lorchel F; d'Hombres A; Mornex F
    Cancer Radiother; 2009 Jan; 13(1):24-9. PubMed ID: 19071051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment.
    Kozak KR; Kachnic LA; Adams J; Crowley EM; Alexander BM; Mamon HJ; Fernandez-Del Castillo C; Ryan DP; DeLaney TF; Hong TS
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1557-66. PubMed ID: 17544599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.